Ketamine Long Therm Follow Up Study

• Conditions: Followin Ketamine Treatment

• Registration Number: NCT04238039
• Lead Sponsor: The Chaim Sheba Medical Center

Brief Summary

Results of the study and of 5 years follow up of depressed patients who participated in the study during 2014-2015. We will locate the participants and will interview them will use the same questionnaires to evaluate their depressive symptoms. We will also measure the time to relapse.

Detailed Description

Anamnestic data will be collected from the patients, in addition, depressive symptoms will be measured using Montgomery Asberg Depression Scale (MADRAS). In addition, the Clinical Global Severity Scale (CGI-S) and Clinical Global Improvement (CGI-I) were performed 2 hours after treatment. In addition, we performed to prolong the time to relapse in this patient.

Study Timeline

• Study Start: 2019-12-14
• Status Verified: 2020-01
• Study First Submitted: 2020-01-18
• Study First Submitted QC: 2020-01-18
• Last Update Submitted: 2020-01-18
• Study First Posted: 2020-01-23
• Last Update Posted: 2020-01-23
• Primary Completion: 2020-02-01
• Study Completion: 2020-04-01

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 16

Inclusion Criteria

• Participants in the ketamine study

Exclusion Criteria

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Time to relapse	5 years	Medications

Trial Locations

Locations (1)

Revital Amiaz; 🇮🇱 Ramat Gan, RI, Israel